We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.4%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.9M |
| 2 |
AutoZone
AZO
|
+$61.2M |
| 3 |
Hershey
HSY
|
+$46.1M |
| 4 |
Intercontinental Exchange
ICE
|
+$41.2M |
| 5 |
General Motors
GM
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$104M |
| 2 |
Biogen
BIIB
|
+$89.3M |
| 3 |
Coca-Cola
KO
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$59.1M |
| 5 |
American Homes 4 Rent
AMH
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Idexx Laboratories
IDXX
$43.9B
| $356K | ﹤0.01% |
1,077
-16,136
| -94% | -$4.67M |
|
852
PTC
PTC
$14.5B
| $355K | ﹤0.01% |
4,564
-14,917
| -77% | -$1.06M |
|
853
Tempest Therapeutics
TPST
$14.9M
| $355K | ﹤0.01% |
1,033
+925
| +856% | +$369K |
|
854
Resources Connection
RGP
$133M
| $353K | ﹤0.01% |
+29,498
| New | +$320K |
|
|
UCB
855
United Community Banks
UCB
$4.21B
| $353K | ﹤0.01% |
17,543
+842
| +5% | +$16.1K |
|
|
AXLA
856
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $353K | ﹤0.01% |
+2,554
| New | +$312K |
|
857
Intellia Therapeutics
NTLA
$1.49B
| $352K | ﹤0.01% |
16,764
-60,674
| -78% | -$1.03M |
|
858
Cummins
CMI
$91.3B
| $351K | ﹤0.01% |
2,027
-21,185
| -91% | -$3.39M |
|
859
Energy Recovery
ERII
$439M
| $347K | ﹤0.01% |
45,697
| – | – |
|
860
Oracle
ORCL
$345B
| $345K | ﹤0.01% |
6,238
-2,576
| -29% | -$136K |
|
861
Fulcrum Therapeutics
FULC
$249M
| $342K | ﹤0.01% |
18,694
+7,502
| +67% | +$118K |
|
|
PTN
862
Palatin Technologies
PTN
$13.9M
| $339K | ﹤0.01% |
+529
| New | +$329K |
|
863
Bankwell Financial Group
BWFG
$513M
| $336K | ﹤0.01% |
+21,150
| New | +$314K |
|
864
Esquire Financial Holdings
ESQ
$1.04B
| $335K | ﹤0.01% |
+19,851
| New | +$315K |
|
|
SUP
865
DELISTED
Superior Industries International
SUP
| $334K | ﹤0.01% |
+196,561
| New | +$281K |
|
866
Westwood Holdings Group
WHG
$186M
| $334K | ﹤0.01% |
+21,175
| New | +$403K |
|
867
Amneal Pharmaceuticals
AMRX
$5.78B
| $333K | ﹤0.01% |
70,049
-177,725
| -72% | -$732K |
|
868
Home Bancorp
HBCP
$553M
| $332K | ﹤0.01% |
12,403
-226
| -2% | -$5.53K |
|
869
Quad
QUAD
$438M
| $332K | ﹤0.01% |
+102,288
| New | +$313K |
|
|
LL
870
DELISTED
LL Flooring Holdings, Inc.
LL
| $329K | ﹤0.01% |
+23,754
| New | +$201K |
|
|
ADMS
871
DELISTED
Adamas Pharmaceuticals
ADMS
| $324K | ﹤0.01% |
126,703
-37,653
| -23% | -$111K |
|
872
J.M. Smucker
SJM
$12.9B
| $322K | ﹤0.01% |
+3,043
| New | +$342K |
|
873
Zebra Technologies
ZBRA
$12.6B
| $320K | ﹤0.01% |
1,250
-130
| -9% | -$30.5K |
|
874
Vaalco Energy
EGY
$552M
| $319K | ﹤0.01% |
257,605
+61,161
| +31% | +$61.4K |
|
875
Solid Biosciences
SLDB
$777M
| $318K | ﹤0.01% |
7,239
+5,238
| +262% | +$217K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2020 Portfolio in Review
As of Q2 2020, Jacobs Levy Equity Management held 1,206 positions worth $9.23B, up 19% from $7.78B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jacobs Levy Equity Management's Q2 2020 filing shows 212 new, 430 increased, 347 reduced and 177 closed positions. Its largest new stake was Lowe's Companies: 259,943 shares worth $35.1M. The largest sale was Mastercard, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q2 2020 buy was Lowe's Companies: 259,943 shares worth $35.1M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2020, an estimated $62.9M increase.
- Jacobs Levy Equity Management's biggest Q2 2020 reduction was Mastercard, cutting an estimated $104M.
- Jacobs Levy Equity Management fully exited Sysco in Q2 2020, selling an estimated $36.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 19% of its $9.23B portfolio in Q2 2020.
- Jacobs Levy Equity Management opened 212 new positions and closed 177 in Q2 2020.
- Jacobs Levy Equity Management's portfolio value rose 19% quarter-over-quarter to $9.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.